Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
Current Dermatology Reports
Published in: Current Dermatology Reports 4/2016

01-12-2016 | Wound Care and Healing (A Friedman, Section Editor)

Wound Dressings: A Comprehensive Review

Authors: Luis J. Borda, Flor E. Macquhae, Robert S. Kirsner

Published in: Current Dermatology Reports | Issue 4/2016

Login to get access

Abstract

Purpose of Review

This comprehensive review covers the advantage and limitations of some dressing materials and the current knowledge on wound dressings and emerging technologies to achieve proper wound healing.

Recent Findings

Traditional and modern dressings are helpful in the wound healing process; however, they cannot substitute lost tissue. Human skin equivalents have been developed conceptually to fill this void as they do not only facilitate wound healing but also may replace lost tissue. Several studies have shown that the addition of mesenchymal stem cells, such as in human placenta, has promising results in wound healing.

Summary

A wound is defined as a disruption in the continuity of the skin or mucosa due to physical or thermal damage, or an underlying medical condition. Wound healing is a complex, dynamic, and multistep process which occurs after skin damage leading to tissue repair. Although the skin normally undergoes repair after a disruption, the healing process can be affected in different conditions such as diabetes mellitus, infections, venous/arterial insufficiency, among others. To enhance healing, a wide range of wound dressings are available; however, a thorough wound assessment (e.g., wound type, size, depth, or color) is required to choose the appropriate dressing. The emergence of new dressings has brought a new perspective of wound healing, but there is no superior product yet to treat acute and/or chronic wounds. Therefore, wound dressing research studies need to be carried out in order to help improve wound healing.
Literature
1.
Boateng JS, Matthews KH, Stevens HN, Eccleston GM. Wound healing dressings and drug delivery systems: a review. J Pharm Sci. 2008;97(8):2892–923.CrossRefPubMed
2.•
Dhivya S, Padma VV, Santhini E. Wound dressings—a review. Biomedicine (Taipei). 2015;5(4):22. Comprehensive review article that offers a critical discussion of several kinds of wound dressings.
3.
Percival JN. Classification of wounds and their management. Surgery. 2002;20:114–7.
4.
Moore K, McCallion R, Searle RJ, Stacey MC, Harding KG. Prediction and monitoring the therapeutic response of chronic dermal wounds. Int Wound J. 2006;3(2):89–96.CrossRefPubMed
5.
Landén NX, Li D, Ståhle M. Transition from inflammation to proliferation: a critical step during wound healing. Cell Mol Life Sci. 2016;73(20):3861–85.
6.
7.
Pereira RF, Bártolo PJ. Traditional therapies for skin wound healing. Adv Wound Care (New Rochelle). 2016;5(5):208–29.CrossRef
8.•
Weller C, Sussman G. Wound dressings update. J Pharm Pract Res. 2006;36:318–24. Review article which covers a thorough description in wound assessment and different types of wound dressings.
9.
Daunton C, Kothari S, Smith L, Steele D. A history of materials and practices for wound management. Wound Pract Res. 2012;20:174–86.
10.
Shah JB. The history of wound care. J Am Col Certif Wound Spec. 2011;3(3):65–6.PubMed
11.
12.
Sung KY, Lee SY. Nonoperative management of extravasation injuries associated with neonatal parenteral nutrition using multiple punctures and a hydrocolloid dressing. Wounds. 2016;28(5):145–51.PubMed
13.
Koksal C, Bozkurt AK. Combination of hydrocolloid dressing and medical compression stockings versus Unna’s Boot for the treatment of venous leg ulcers. Swiss Med Wkly. 2003;133(25–26):364–8.PubMed
14.
Jiang Q, Zhou W, Wang J, Tang R, Zhang D, Wang X. Hypromellose succinate-crosslinked chitosan hydrogel films for potential wound dressing. Int J Biol Macromol. 2016;91:85–91.CrossRefPubMed
15.
Wichterle O, Lim D. Hydrophilic gels for biological use. Nature. 1960;185:117–8.CrossRef
16.
Jayakumar R, Rajkumar M, Freitas H, Selvamurugan N, Nair SV, Furuike T, et al. Preparation, characterization, bioactive and metal uptake studies of alginate/phosphorylated chitin blend films. Int J Biol Macromol. 2009;44(1):107–11.CrossRefPubMed
17.
Wang T, Qisheng G, Zhao J, Mei J, Shao M, Pan Y, et al. Calcium alginate enhances wound healing by up-regulating the ratio of collagen types I/III in diabetic rats. Int J Clin Exp Pathol. 2015;8(6):6636–45.PubMedPubMedCentral
18.
Balakrishnan B, Mohanty M, Umashankar PR, Jayakrishnan A. Evaluation of an in situ forming hydrogel wound dressing based on oxidized alginate and gelatin. Biomaterials. 2005;26:6335–42.CrossRefPubMed
19.
Kurczewska J, Sawicka P, Ratajczak M, Gajęcka M, Schroeder G. Will the use of double barrier result in sustained release of vancomycin? Optimization of parameters for preparation of a new antibacterial alginate-based modern dressing. Int J Pharm. 2015;496(2):526–33.CrossRefPubMed
20.
Kuo CK, Ma PX. Ionically crosslinked alginate hydrogels as scaffolds for tissue engineering: part 1. Structure, gelation rate and mechanical properties. Biomaterials. 2001;2(6):511–21.CrossRef
21.
Blair SD, Jarvis P, Salmon M, McCollum C. Clinical trial of calcium alginate haemostatic swabs. Br J Surg. 1990;77:568–70.CrossRefPubMed
22.
Blair SD, Backhouse CM, Harper R, Matthews J, McCollum CN. Comparison of absorbable materials for surgical haemostasis. Br J Surg. 1988;75:69–71.CrossRef
23.
Segal HC, Hunt BJ, Gilding K. The effects of alginate and non-alginate wound dressings on blood coagulation and platelet activation. J Biomater Appl. 1998;12:249–57.PubMed
24.
Thomas A, Harding KG, Moore K. Alginates from wound dressings activate human macrophages to secrete tumor necrosis factor-alpha. Biomaterials. 2000;21(17):1797–802.CrossRefPubMed
25.
Schmidt RJ, Turner TD. Calcium alginate dressings. Pharm J. 1986;236:578.
26.
Doyle JW, Roth T, Smith M. Effects of calcium alginate on cellular wound healing processes modelled in vitro. J Biomed Mater Res. 1996;32(4):561–8.
27.
Morgan DA. Wounds: what should a dressing formulary include? Hosp Pharm. 2009;9:261–6.
28.•
Vermeulen H, Ubbink DT, Goossens A, de Vos R, Legemate DA. Systematic review of dressings and topical agents for surgical wounds healing by secondary intention. Br J Surg. 2005;92(6):665–72. Epidemiological study which highlights the differences between dressings and topical agents.
29.
Ramos-e-Silva M, Ribeiro de Castro MC. New dressings, including tissue-engineered living skin. Clin Dermatol. 2002;20(6):715–23.CrossRefPubMed
30.
Ramshaw JA, Werkmeister JA, Glattauer V. Collagen-based biomaterials. Biotechnol Genet Eng Rev. 1996;13:335–82.CrossRefPubMed
31.
González A. Use of collagen extracellular matrix dressing for the treatment of a recurrent venous ulcer in a 52-year-old patient. J Wound Ostomy Continence Nurs. 2016;43(3):310–2.CrossRefPubMed
32.
Doillon CJ, Silver FH. Collagen-based wound dressing: effects of hyaluronic acid and fibronectin on wound healing. Biomaterials. 1986;7(1):3–8.CrossRefPubMed
33.
Lee M, Han SH, Choi WJ, Chung KH, Lee JW. Hyaluronic acid dressing (Healoderm) in the treatment of diabetic foot ulcer: a prospective, randomized, placebo-controlled, single-center study. Wound Repair Regen. 2016;24(3):581–8.CrossRefPubMed
34.
Ferrari R, Boracchi P, Romussi S, Ravasio G, Stefanello D. Application of hyaluronic acid in the healing of non-experimental open wounds: a pilot study on 12 wounds in 10 client-owned dogs. Vet World. 2015;8(10):1247–59.CrossRefPubMedPubMedCentral
35.
Ishihara M, Nakanishi K, Ono K, Sato M, Kikuchi M, Saito Y, et al. Photocrosslinkable chitosan as a dressing for wound occlusion and accelerator in healing process. Biomaterials. 2002;23(3):833–40.CrossRefPubMed
36.
Abdel-Mohsen AM, Jancar J, Massoud D, Fohlerova Z, Elhadidy H, Spotz Z, et al. Novel chitin/chitosan-glucan wound dressing: isolation, characterization, antibacterial activity and wound healing properties. Int J Pharm. 2016;510(1):86–99.CrossRefPubMed
37.
Anjum S, Arora A, Alam MS, Gupta B. Development of antimicrobial and scar preventive chitosan hydrogel wound dressings. Int J Pharm. 2016;508(1–2):92–101.CrossRefPubMed
38.
Fan X, Chen K, He X, Li N, Huang J, Tang K, et al. Nano-TiO2/collagen-chitosan porous scaffold for wound repairing. Int J Biol Macromol. 2016;91:15–22.CrossRefPubMed
39.
Choi SM, Ryu HA, Lee KM, Kim HJ, Park IK, Cho WJ, et al. Development of stabilized growth factor-loaded hyaluronate-collagen dressing (HCD) matrix for impaired wound healing. Biomater Res. 2016;20:9.CrossRefPubMedPubMedCentral
40.
Catanzano O, D’Esposito V, Acierno S, Ambrosio MR, De Caro C, Avagliano C, et al. Alginate-hyaluronan composite hydrogels accelerate wound healing process. Carbohydr Polym. 2015;131:407–14.CrossRefPubMed
41.
Mian M, Beghè F, Mian E. Collagen as a pharmacological approach in wound healing. Int J Tissue React. 1992;14(Suppl):1–9.PubMed
42.
Ruszczak Z, Friess W. Collagen as a carrier for on-site delivery of antibacterial drugs. Adv Drug Deliv Rev. 2003;55(12):1679–98.CrossRefPubMed
43.•
Dreifke MB, Jayasuriya AA, Jayasuriya AC. Current wound healing procedures and potential care. Mater Sci Eng C Mater Biol Appl. 2015;48:651–62. Analytical review of wound dressings based on biocompatible polymers.
44.
Dreifke MB, Ebraheim NA, Jayasuriya AC. Investigation of potential injectable polymeric biomaterials for bone regeneration. J Biomed Mater Res A. 2013;101(8):2436–47.CrossRefPubMedPubMedCentral
45.
Turley EA, Torrance J. Localization of hyaluronate and hyaluronate-binding protein on motile and non-motile fibroblasts. Exp Cell Res. 1985;161(1):17–28.CrossRefPubMed
46.
Moczar M, Robert L. Stimulation of cell proliferation by hyaluronidase during in vitro aging of human skin fibroblasts. Exp Gerontol. 1993;28(1):59–68.CrossRefPubMed
47.
Ghazi K, Deng-Pichon U, Warnet JM, Rat P. Hyaluronan fragments improve wound healing on in vitro cutaneous model through P2X7 purinoreceptor basal activation: role of molecular weight. PLoS One. 2012;7(11):e48351.CrossRefPubMedPubMedCentral
48.
Abdel-Mohsen AM, Jancar J, Massoud D, Fohlerova Z, Elhadidy H, Spotz Z, Hebeish A. Novel chitin/chitosan-glucan wound dressing: Isolation, characterization, antibacterial activity and wound healing properties. Int J Pharm. 2016;510(1):86–99.
49.
Ueno H, Mori T, Fujinaga T. Topical formulations and wound healing applications of chitosan. Adv Drug Deliv Rev. 2001;52(2):105–15.CrossRefPubMed
50.
Moura LI, Dias AM, Leal EC, Carvalho L, de Sousa HC, Carvalho E. Chitosan-based dressings loaded with neurotensin—an efficient strategy to improve early diabetic wound healing. Acta Biomater. 2014;10(2):843–57.CrossRefPubMed
51.
Kirichenko AK, Bolshakov IN, Ali-Riza AE, Vlasov AA. Morphological study of burn wound healing with the use of collagen-chitosan wound dressing. Bull Exp Biol Med. 2013;154(5):692–6.CrossRefPubMed
52.
Choi JS, Kim JD, Yoon HS, Cho YW. Full-thickness skin wound healing using human placenta-derived extracellular matrix containing bioactive molecules. Tissue Eng Part A. 2013;19(3–4):329–39.CrossRefPubMed
53.
Wojtowicz AM, Oliveira S, Carlson MW, Zawadzka A, Rousseau CF, Baksh D. The importance of both fibroblasts and keratinocytes in a bilayered living cellular construct used in wound healing. Wound Repair Regen. 2014;22(2):246–55.CrossRefPubMedPubMedCentral
54.
Nathoo R, Howe N, Cohen G. Skin substitutes: an overview of the key players in wound management. J Clin Aesthet Dermatol. 2014;7(10):44–8.PubMedPubMedCentral
55.
Centanni JM, Straseski JA, Wicks A, et al. StrataGraft skin substitute is well-tolerated and is not acutely immunogenic in patients with traumatic wounds: results from a prospective, randomized, controlled dose escalation trial. Ann Surg. 2011;253(4):672–83.CrossRefPubMedPubMedCentral
56.
Sun T, Han Y, Chai J, Yang H. Transplantation of microskin autografts with overlaid selectively decellularized split thickness porcine skin in the repair of deep burn wounds. J Burn Care Res. 2011;32(3):e67–73.CrossRefPubMed
57.
Marston WA, Hanft J, Norwood P, Pollak R, Dermagraft Diabetic Foot Ulcer Study Group. The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers, results of a prospective randomized trial. Diabetes Care. 2003;26(6):1701–5.CrossRefPubMed
58.
Límová M. Active wound coverings: bioengineered skin and dermal substitutes. Surg Clin North Am. 2010;90(6):1237–55.CrossRefPubMed
59.
Falanga V, Sabolinski M. A bilayered living skin construct (APLIGRAF) accelerates complete closure of hard-to-heal venous ulcers. Wound Repair Regen. 1999;7(4):201–7.CrossRefPubMed
60.
Marston WA, Sabolinski ML, Parsons NB, Kirsner RS. Comparative effectiveness of a bilayered living cellular construct and a porcine collagen wound dressing in the treatment of venous leg ulcers. Wound Repair Regen. 2014;22(3):334–40.CrossRefPubMed
61.
Falabella AF, Valencia IC, Eaglstein WH, Schachner LA. Tissue-engineered skin (Apligraf) in the healing of patients with epidermolysis bullosa wounds. Arch Dermatol. 2000;136(10):1225–30.CrossRefPubMed
62.
Muhart M, McFalls S, Kirsner RS, Elgart GW, Kerdel F, Sabolinski ML, et al. Behavior of tissue-engineered skin: a comparison of a living skin equivalent, autograft, and occlusive dressing in human donor sites. Arch Dermatol. 1999;135(8):913–8.CrossRefPubMed
63.
Mathur M, De A, Gore M. Microbiological assessment of cadaver skin grafts received in a Skin Bank. Burns. 2009;35(1):104–6.CrossRefPubMed
64.
Brigido SA. The use of an acellular dermal regenerative tissue matrix in the treatment of lower extremity wounds: a prospective 16-week pilot study. Int Wound J. 2006;3(3):181–7.CrossRefPubMed
65.
González Alaña I, Torrero López JV, Martín Playá P, Gabilondo Zubizarreta FJ. Combined use of negative pressure wound therapy and Integra® to treat complex defects in lower extremities after burns. Ann Burns Fire Disasters. 2013;26(2):90–3.PubMedPubMedCentral
66.
Park CA, Defranzo AJ, Marks MW, Molnar JA. Outpatient reconstruction using Integra and sub atmospheric pressure. Ann Plast Surg. 2009;62(2):164–9.CrossRefPubMed
67.
Molnar JA, DeFranzo AJ, Hadaegh A, Morykwas MJ, Shen P, Argenta LC. Acceleration of Integra incorporation in complex tissue defects with sub atmospheric pressure. Plast Reconstr Surg. 2004;113(5):1339–46.CrossRefPubMed
68.
Raimer DW, Group AR, Petitt MS, Nosrati N, Yamazaki ML, Davis NA, et al. Porcine xenograft biosynthetic wound dressings for the management of postoperative Mohs wounds. Dermatol Online J. 2011;17(9):1.PubMed
69.
Romanelli M, Dini V, Bertone MS. Randomized comparison of OASIS wound matrix versus moist wound dressing in the treatment of difficult-to-heal wounds of mixed arterial/venous etiology. Adv Skin Wound Care. 2010;23(1):34–8.CrossRefPubMed
70.•
Mostow EN, Haraway GD, Dalsing M, Hodde JP, King D, OASIS Venus Ulcer Study Group. Effectiveness of an extracellular matrix graft (OASIS Wound Matrix) in the treatment of chronic leg ulcers: a randomized clinical trial. J Vasc Surg. 2005;41(5):837–43. One of the first papers to show the effectiveness of this graft in VLUs. This paper may have increased the frequency of using this graft for VLUs treatment.
71.
Palmer BL, Gantt DS, Lawrence ME, Rajab MH, Dehmer GJ. Effectiveness and safety of manual hemostasis facilitated by the SyvekPatch with one hour of bedrest after coronary angiography using six-French catheters. Am J Cardiol. 2004;93(1):96–7.CrossRefPubMed
72.
Lindner HB, Zhang A, Eldridge J, Demcheva M, Tsichlis P, et al. Anti-bacterial effects of poly-N-acetyl-glucosamine nanofibers in cutaneous wound healing: requirement for Akt1. PLoS One. 2011;6(4):e18996.CrossRefPubMedPubMedCentral
73.
Pietramaggiori G, Yang HJ, Scherer SS, Kaipainen A, Chan RK, et al. Effects of poly-N-acetyl glucosamine (pGlcNAc) patch on wound healing in db/db mouse. J Trauma. 2008;64(3):803–8.CrossRefPubMed
74.
Scherer SS, Pietramaggiori G, Matthews J, Perry S, Assmann A, et al. Poly-N-acetyl glucosamine nanofibers: a new bioactive material to enhance diabetic wound healing by cell migration and angiogenesis. Ann Surg. 2009;250(2):322–30.CrossRefPubMed
75.
Kelechi TJ, Mueller M, Hankin CS, Bronstone A, Samies J, et al. A randomized, investigator-blinded, controlled pilot study to evaluate the safety and efficacy of a poly-N-acetyl glucosamine-derived membrane material in patients with venous leg ulcers. J Am Acad Dermatol. 2012;66(6):e209–15.CrossRefPubMed
76.
Maxson S, Lopez EA, Yoo D, Danilkovitch-Miagkova A, Leroux MA. Concise review: role of mesenchymal stem cells in wound repair. Stem Cells Transl Med. 2012;1(2):142–9.CrossRefPubMedPubMedCentral
77.
Shin L, Peterson DA. Human mesenchymal stem cell grafts enhance normal and impaired wound healing by recruiting existing endogenous tissue stem/progenitor cells. Stem Cells Transl Med. 2013;2(1):33–42.CrossRefPubMed
78.
Faulk WP, Matthews R, Stevens PJ, Bennett JP, Burgos H, et al. Human amnion as an adjunct in wound healing. Lancet. 1980;1:1156–8.CrossRefPubMed
79.
Gibbons GW. Grafix®, a cryopreserved placental membrane, for the treatment of chronic/stalled wounds. Adv Wound Care (New Rochelle). 2015;4(9):534–44.CrossRef
80.•
Lavery LA, Fulmer J, Shebetka KA, et al. The efficacy and safety of Grafix((R)) for the treatment of chronic diabetic foot ulcers: results of a multicentre, controlled, randomized, blinded, clinical trial. Int Wound J. 2014;11:554–60. Seminal study which demonstrates this graft as a good option for DFUs. This paper may have expanded this graft use to other pathologies.
81.
Regulski M, Jacobstein DA, Petranto RD, Migliori VJ, Nair G, et al. A retrospective analysis of a human cellular repair matrix for the treatment of chronic wounds. Ostomy Wound Manage. 2013;59:38–43.PubMed
82.
Zelen CM, Serena TE, Denoziere G, Fetterolf DE. A prospective randomised comparative parallel study of amniotic membrane wound graft in the management of diabetic foot ulcers. Int Wound J. 2013;10(5):502–7.CrossRefPubMedPubMedCentral
83.
Fetterolf DE, Istwan NB, Stanziano GJ. An evaluation of healing metrics associated with commonly used advanced wound care products for the treatment of chronic diabetic foot ulcers. Manag Care. 2014;23:31–8.PubMed
84.
Zelen CM, Gould L, Serena TE, Carter MJ, Keller J, Li WW. A prospective, randomised, controlled, multi-centre comparative effectiveness study of healing using dehydrated human amnion/chorion membrane allograft, bioengineered skin substitute or standard of care for treatment of chronic lower extremity diabetic ulcers. Int Wound J. 2015;12(6):724–32.CrossRefPubMed
85.
Amin N, Doupis J. Diabetic foot disease: from the evaluation of the “foot at risk” to the novel diabetic ulcer treatment modalities. World J Diabetes. 2016;7(7):153–64.CrossRefPubMedPubMedCentral
86.
Phaechamud T, Issarayungyuen P, Pichayakorn W. Gentamicin sulfate-loaded porous natural rubber films for wound dressing. Int J Biol Macromol. 2016;85:634–44.CrossRefPubMed
87.
Meaume S, Vallet D, Morere MN, Téot L. Evaluation of a silver-releasing hydroalginate dressing in chronic wounds with signs of local infection. J Wound Care. 2005;14(9):411–9.CrossRefPubMed
88.
Denkbaş EB, Oztürk E, Ozdemir N, Keçeci K, Agalar C. Norfloxacin-loaded chitosan sponges as wound dressing material. J Biomater Appl. 2004;18(4):291–303.CrossRefPubMed
89.
Aoyagi S, Onishi H, Machida Y. Novel chitosan wound dressing loaded with minocycline for the treatment of severe burn wounds. Int J Pharm. 2007;330(1–2):138–45.CrossRefPubMed
90.
Jung WK, Koo HC, Kim KW, Shin S, Kim SH, Park YH. Antibacterial activity and mechanism of action of the silver ion in Staphylococcus aureus and Escherichia coli. Appl Environ Microbiol. 2008;74(7):2171–8.CrossRefPubMedPubMedCentral
91.
Komarcević A. The modern approach to wound treatment. Med Pregl. 2000;53(7–8):363–8 [Article in Croatian].PubMed
92.
Huang G, Sun T, Zhang L, Wu Q, Zhang K, Tian Q, et al. Combined application of alginate dressing and human granulocyte-macrophage colony stimulating factor promotes healing in refractory chronic skin ulcers. Exp Ther Med. 2014;7(6):1772–6.PubMedPubMedCentral
93.
Yan H, Chen J, Peng X. Recombinant human granulocyte-macrophage colony-stimulating factor hydrogel promotes healing of deep partial thickness burn wounds. Burns. 2012;38(6):877–81.CrossRefPubMed
94.
Da Costa RM, Ribeiro Jesus FM, Aniceto C, Mendes M. Randomized, double-blind, placebo-controlled, dose-ranging study of granulocyte-macrophage colony stimulating factor in patients with chronic venous leg ulcers. Wound Repair Regen. 1999;7(1):17–25.CrossRefPubMed
95.
Khanbanha N, Atyabi F, Taheri A, Talaie F, Mahbod M, Dinarvand R. Healing efficacy of an EGF impregnated triple gel based wound dressing: in vitro and in vivo studies. Biomed Res Int. 2014;2014:493732.CrossRefPubMedPubMedCentral
96.
Shi L, Ermis R, Kiedaisch B, Carson D. The effect of various wound dressings on the activity of debriding enzymes. Adv Skin Wound Care. 2010;23(10):456–62.CrossRefPubMed
97.
98.
Miller JD, Carter E, Hatch DC, Zhubrak M, Giovinco NA, Armstrong DG. Use of collagenase ointment in conjunction with negative pressure wound therapy in the care of diabetic wounds: a case series of six patients. Diabet Foot Ankle. 2015;6:24999.PubMed
99.
Singh D, Singh R. Papain incorporated chitin dressings for wound debridement sterilized by gamma radiation. Radiat Phys Chem. 2012;81:1781–5.CrossRef
100.
Mustafah NM, Chung TY. Papase as a treatment option for the overgranulating wound. J Wound Care. 2014;23(2 Suppl):S10–2.CrossRefPubMed
Metadata
Title
Wound Dressings: A Comprehensive Review
Authors
Luis J. Borda
Flor E. Macquhae
Robert S. Kirsner
Publication date
01-12-2016
Publisher
Springer US
Published in
Current Dermatology Reports / Issue 4/2016
Electronic ISSN: 2162-4933
DOI
https://doi.org/10.1007/s13671-016-0162-5

Other articles of this Issue 4/2016

Current Dermatology Reports 4/2016 Go to the issue

Wound Care and Healing (A Friedman, Section Editor)

Updates on Keloidal Wound Healing

Wound Care and Healing (A Friedman, Section Editor)

Human as the Ultimate Wound Healing Model: Strategies for Studies Investigating the Dermal Lipidome

Teledermatology (D Oh, Section Editor)

Invited Commentary on Teledermatology Education: the Evidence, the Tools, and the Potential ECHO

Wound Care and Healing (A Friedman, Section Editor)

Leg Ulcers in Dermatology

Wound Care and Healing (A Friedman, Section Editor)

Nanomaterials for Wound Healing

Wound Care and Healing (A Friedman, Section Editor)

Vasculitic Diseases and Prothrombotic States Contributing to Delayed Healing in Chronic Wounds